EligibleTrials

Pathological Response After Neoadjuvant Treatment on NSCLC

Recruiting · NCT05167487 · Observational (researchers observe without assigning treatment)

View the official record on ClinicalTrials.gov →
Lung cancer

Interventions studied

CarboplatinCisplatin

What this trial is about

This is a non-interventional, observational, multicenter and retrospective study. Being limited to the collection of patient data already filled in the Tumor Thoracic Registry data base and the data from stage IIIA clinical trials case report forms.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

17 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.